CN101144775B - Bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit - Google Patents
Bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit Download PDFInfo
- Publication number
- CN101144775B CN101144775B CN200710070629A CN200710070629A CN101144775B CN 101144775 B CN101144775 B CN 101144775B CN 200710070629 A CN200710070629 A CN 200710070629A CN 200710070629 A CN200710070629 A CN 200710070629A CN 101144775 B CN101144775 B CN 101144775B
- Authority
- CN
- China
- Prior art keywords
- bacteria
- pcr
- reagent kit
- reactant liquor
- fluorescence quantitative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 39
- 238000001514 detection method Methods 0.000 title claims abstract description 35
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 12
- 238000012339 Real-time fluorescence quantitative polymerase chain reaction Methods 0.000 title claims abstract description 7
- 238000003753 real-time PCR Methods 0.000 claims abstract description 22
- 239000013642 negative control Substances 0.000 claims abstract description 11
- 238000012856 packing Methods 0.000 claims abstract description 4
- 239000000523 sample Substances 0.000 claims description 28
- 239000000376 reactant Substances 0.000 claims description 15
- 239000006166 lysate Substances 0.000 claims description 10
- 239000013558 reference substance Substances 0.000 claims description 9
- 241000588724 Escherichia coli Species 0.000 claims description 7
- 238000011144 upstream manufacturing Methods 0.000 claims description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 230000009849 deactivation Effects 0.000 claims description 2
- 238000005374 membrane filtration Methods 0.000 claims description 2
- 239000008227 sterile water for injection Substances 0.000 claims description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- 238000012360 testing method Methods 0.000 abstract description 9
- 244000052769 pathogen Species 0.000 abstract description 8
- 230000001717 pathogenic effect Effects 0.000 abstract description 8
- 208000035143 Bacterial infection Diseases 0.000 abstract description 7
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 5
- 239000013641 positive control Substances 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000002028 premature Effects 0.000 abstract description 3
- 239000012295 chemical reaction liquid Substances 0.000 abstract 3
- 239000012139 lysis buffer Substances 0.000 abstract 2
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 15
- 108020004465 16S ribosomal RNA Proteins 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 10
- 206010040047 Sepsis Diseases 0.000 description 9
- 208000013223 septicemia Diseases 0.000 description 9
- 238000009640 blood culture Methods 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 201000009906 Meningitis Diseases 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010048612 Hydrothorax Diseases 0.000 description 2
- 208000031662 Noncommunicable disease Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000003578 bacterial chromosome Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 102000011767 Acute-Phase Proteins Human genes 0.000 description 1
- 108010062271 Acute-Phase Proteins Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention provides a reagent kit for testing the bacteria real time fluorescence quantitative polymerase chain reaction, and the reagent kit comprises a PCR reaction liquid tube 1, a standard 2, a positive control 3, a negative control 4, a lysis buffer extracting 5, an operating manual 6 and a packing box body 7, wherein, the box body 7 is provided with a container hole, where the PCR reaction liquid tube 1, the standard 2, the positive control 3, the negative control 4 and the lysis buffer extracting 5 are respectively arranged, the PCR reaction liquid tube is subpackaged by a single tube, and arranged in matrix. The reagent kit can be used in the bacteria DNA detecting. The invention achieves the purpose of the universal detection to the common bacteria by applying the real time fluorescence quantitative PCR technology, to effectively solve the problem that the PCR method is only used to detect unitary pathogenic bacteria, the common bacterial infection is detected versatilely, the versatility and the sensibility of the bacteria detecting are advanced, and a basis of the premature pathogen detecting of the bacterial infection disease is provided.
Description
Technical field
The invention belongs to biological technical field, relate to quantitative PCR detection kit, be specifically related to the kit that a kind of real-time fluorescence quantitative PCR bacterial detection sexuality is caught DNA of bacteria in youngster's blood, cerebrospinal fluid, hydrothorax, the ascites equal samples.
Background technology
Bacterial 16 S rRNA gene is the corresponding dna sequence dna of coding rRNA on the bacterial chromosome.This gene has following two big characteristics: (1) multicopy: 16S rRNA encoding gene is present in all bacterial chromosome genomes with the multicopy form, and each bacterium contains 5~10 copies approximately, and this feasible detection to this gene has susceptibility.(2) many information: 16S rRNA encoding gene inner structure is made up of variable region and conserved region.Conserved region is that all bacteriums are common, and the title of " molecular fossil " is arranged.Can be used for the general detection of clinical common bacteria according to universal primer and the general probe of the various bacteriums of conserved regions design.At present, the 16S rRNA gene sequencing of nearly all pathogen is finished.Therefore 16S rRNA gene has become comparatively ideal clinical bacteria infection detection target-gene sequence, becomes the goldstandard that bacterium and other pathogen are differentiated, classified gradually.
The ultimate principle of real time fluorescent quantitative technology: utilize 5 of Taq enzyme '-3 ' excision enzyme nucleic acid activity, on the regular-PCR basis, design fluorescence double-tagging probe, fluorescence report group (R) and quenching group (Q) on the mark respectively.When this probe was kept perfectly, the fluorescence signal of R group was suppressed by the Q group, in case probe is cut off, inhibiting effect disappears, and the fluorescence signal of R group just can be detected.This method adopts complete stopped pipe to detect, and has saved the product postprocessing to PCR, has avoided cross pollution, and result's judgement is finished by computing machine, has simplified operation steps, and has increased result's reliability.
Septicemia (Septicemia) is meant pathogen and the caused clinical syndrome of toxin intrusion blood flow thereof.The activation and the release of inflammatory mediator are often arranged in the course of disease, cause high heat, shiver, tachycardia, be short of breath, a series of clinical symptoms such as fash and mind change, severe patient can cause shock, DIC and MOF.Even give suitable antibiotic therapy, case fatality rate is still higher.Children particularly the neonate because self resistibility is poor, skin thin tender, birth back umbilical region does not heal etc. all easily suffers from septicemia.If children's septicemia can not judge in early days, in time, treatment up hill and dale, can cause purulent meningitis and take place, influence developing infantile intelligence and grow, cause children's permanent disability and dead.
Children's septicemia lacks specificity clinical symptoms and early stage lab index reliably, and early diagnosis is very difficult.At present existing kinds of experiments chamber method is applied in the diagnosis of children's septicemia, as blood culture, routine blood test, acute phase protein such as CRP, focus secretion is cultivated and smear, pathogen Detection of antigen such as counter immunoelectrophoresis (CIE), and molecular Biological Detection such as methods such as restriction endonuclease analysis (RFLP), dna probe.Fluorescence quantitative PCR method is the biology techniques that rose in recent years, has characteristics such as accuracy height, favorable reproducibility, has been widely used in numerous areas such as gene expression research, pathogen detection, snp analysis, is one of present research focus in detection with application.
Along with the develop rapidly of Protocols in Molecular Biology and the widespread use in medical research thereof, the new method of setting up bacterial infection diseases such as rapid and reliable diagnosis children's septicemia and purulent meningitis has become and may and have been attempted.
Summary of the invention
The purpose of this invention is to provide bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit, this quantification kit is by quantitative PCR reactant liquor, standard items, reference substance, extracting lysate, operational manual, Packaging box body are formed, Packaging box body is provided with container hole, place PCR reactant liquor pipe, standard items, positive reference substance, negative control product, extracting lysate respectively, PCR reactant liquor pipe is by single tube packing, arranged.
Wherein the quantitative PCR reactant liquor contains PCR damping fluid, MgCl
2, dNTPs, Bacteria Detection with upstream primer, detect with downstream primer, fluorescence probe, hot resistant DNA polymerase (Taq archaeal dna polymerase) and form.The extracting lysate contains 10mmol/L Tri-HCl, and pH 7.6,5mmol/L disodium ethylene diamine tetraacetate (EDTA), 0.5% lauryl sodium sulfate (SDS).The quantitative PCR reactant liquor must be with 0.22 μ m membrane filtration pre-service.
Wherein:
The upstream primer sequence is: 5`-CAACGCGAAGAACCTTACC-3`
The downstream primer sequence is: 5 '-ACGTCATCCCCACCTTCC-3 '.
The fluorescence probe sequence is: 5 '-FAM-TAAGTCCCGCAACGAGCGCAA-TAMRA-3 '.
The standard items sequence is:
CAACGCGAAG?AACCTTACCT?GGTCTTGACA?TCCACAGAAC?TTTCCAGAGA
TGGATTGGTG?CCTTCGGGAA?CTGTGAGACA?GGTGCTGCAT?GGCTGTCGTC
AGCTCGTGTT?GTGAAATGTT?GGGTTAAGTC?CCGCAACGAG?CGCAACCCTT
ATCCTTTGTT?GCCAGCGGTC?CGGCCGGGAA?CTCAAAGGAG?ACTGCCAGTG
ATAAACTGGA?GGAAGGTGGG?GATGACGT
Reference substance is divided into positive reference substance and negative control product, and negative control is the sterile water for injection sample, and positive control is an Escherichia coli deactivation DNA sample.
This quantitative reagent is stored in-20 ℃, reduces multigelation as far as possible.
Second purpose of the present invention provides the application of this kit in bacterial detection DNA.
This product is selected the amplified target zone of clinical common bacteria 16S rRNA gene high conservative for use, and design bacterium universal primer and general TaqMan fluorescence probe utilize the real-time fluorescence quantitative PCR technology, and real-time quantitative detects the application of clinical sample DNA of bacteria.
Kit using method of the present invention:
Each detection all should be set up positive control and negative control.Standard items are 1 * 10 with the aseptic deionized water dilution
2-1 * 10
9Copy/ml.
DNA of bacteria is extracted: gather fresh whole blood 1ml and be positioned in the aseptic vacuum test tube that contains Chinese holly edge acid sodium anti-freezing liquid collecting, mixing is got extracting lysate (the 10mmol/L Tri-HCl pH7.65mmol/L EDTA that whole blood 50ul adds equivalent, 0.5%SDS) put 100 ℃ and boil 10min, the centrifugal 5min of 12000r/min gets 5 μ l supernatants as pcr template.Bacterium liquid, cerebrospinal fluid, hydrothorax, ascites equal samples method are the same.
Augmentation detection: on quantitative real time PCR Instrument, carry out cumulative volume 50 μ l, 45.0 μ l PCR reactant liquors wherein, 5 μ l test sample (extracting product, standard items, positive or negative contrast).Reaction conditions: 94 ℃ of pre-sex change of 5min, 94 ℃ of 20sec, 60 ℃ of 60sec are a circulation, circulate altogether 40 times.
Fluorescent quantitation result report: 1. CT value (threshold cycle, the period that fluorescence signal in each reaction tube is experienced when reaching the thresholding of setting) it is negative to equal 40.0 sample, 2. the sample of CT value≤35, testing result is positive, 3. the CT value is ash value zone between 35~40, and the back of reforming is negative greater than 38 values.According to the typical curve that is obtained, calculate the amount (copy number/ml) of bacterium in each sample to be measured.
Usefulness of the present invention is: this method utilization real-time fluorescence quantitative PCR technology has realized the purpose to the general detection of clinical common bacteria.Solve the problem that PCR method in the past can only be used to detect single pathogen effectively, common bacterial infection has been carried out general detection, improved the versatility and the susceptibility of Bacteria Detection, improved the bacillary and abacterial ability distinguished.For the early stage pathogen detection of bacterial infection provides foundation.
Description of drawings
Fig. 1 is a structural representation of the present invention.
Fig. 2 is Escherichia coli standard items fragment sequences.
Fig. 3 is that bacteria real-time fluorescence quantitative PCR standard items detect.
Fig. 4 is a bacteria real-time fluorescence quantitative PCR typical curve.
Embodiment
The present invention is described further with specific embodiment in conjunction with the accompanying drawings.Should be appreciated that these embodiment only are used for illustration purpose, and are not used in the restriction scope of the invention.
Referring to Fig. 1, bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit provided by the invention is made up of PCR reactant liquor 1, standard items 2, positive reference substance 3, negative control product 4, extracting lysate 5, operational manual 6, Packaging box body 7.Box body 7 is provided with container hole, places PCR reactant liquor pipe 1, standard items 2, positive reference substance 3, negative control product 4, extracting lysate 5 respectively, and PCR reactant liquor pipe is by single tube packing, arranged.
Wherein the quantitative PCR reactant liquor contains PCR damping fluid, MgCl
2, dNTPs, Bacteria Detection with upstream primer, detect with downstream primer, fluorescence probe, hot resistant DNA polymerase (Taq archaeal dna polymerase) and form.The extracting lysate contains 10mmol/L Tri-HCl, and pH 7.6,5mmol/L disodium ethylene diamine tetraacetate (EDTA), 0.5% lauryl sodium sulfate (SDS).
One, material:
Clinical common bacteria isolated strains staphylococcus aureus, Staphylococcus epidermidis and Escherichia coli provide by this laboratory cultures; PCR related reagents such as pGEM-T-Easy cloning system, Taq archaeal dna polymerase, dNTP are available from U.S. Promega company, and sequencing reagent, 377 type sequenators, PE-5700 type quantitative PCR instrument are U.S. Perkin Elmer company product.
Two, primer and probe design and synthetic:
Select clinical 50 bacterial strains of 22 kinds of Pseudomonas of common bacteria that cause septicemia and purulent meningitis (change brain), wherein removing from office blue yin and yang attribute bacterial strain respectively is 25 strains (seeing Table 1).Use its 16S rRNA gene order of MEGALIGN software analysis, seek the conservative fragments between the different bacterium kind, analyze the rule of biological evolution tree, according to the principle of design of primer and probe, at these bacterium conservative region screening universal primer and general probe, therefrom select best a pair of combination.
The upstream primer sequence is: 5`-CAACGCGAAGAACCTTACC-3`
The downstream primer sequence is: 5 '-ACGTCATCCCCACCTTCC-3 ' is synthetic by the living worker in Shanghai company.
The fluorescence probe sequence is: 5 '-FAM-TAAGTCCCGCAACGAGCGCAA-TAMRA-3 '.Precious biotech company is synthetic by Dalian.
The clinical common bacteria that causes septicemia and purulent meningitis (change brain) of table 1
Three, examination criteria product preparation:
With above-mentioned primer amplification reference culture Escherichia coli, the PCR product is 228bp, the PCR product promptly inserts the pGEM-T-Easy cloning vector with cloning system after electrophoresis detection, extracting recombinant clone plasmid carries out sequence verification with carrier primer M13R to the positive colony of recombinating.Measure concentration and be converted into (copy number/volume).
The result: through order-checking, above-mentioned design standards product conform to expection fully, and standard items fragment sequence wherein is an Escherichia coli, referring to Fig. 2.
Four, clinical common bacterial strain gradient dilution control test:
From the nutrient culture media of three kinds of common clinical separation strains (staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli), scrape the bacterial plaque that takes a morsel respectively with aseptic cotton carrier, be put in separately in the test tube of the sterilized water that contains 2ml, use to be made into the liquid of 0.5 titre than turbid instrument (being equivalent to concentration is 10
8CFU/m1).Respectively these three kinds of bacterial strains are carried out 10 successively
-1Inferior, 10
-2Inferior, 10
-3Inferior, 10
-4Inferior, 10
-5The power dilution respectively gets 10
-5Inferior, 10
-4Inferior, 10
-3Power dilution 5ul fluorescent quantitation and draw 37 ℃ of cultivations overnight of dull and stereotyped bacterium is counted the clump count of double dish next day.
Table 2 plate count and fluorescence quantitative PCR detection result contrast
One, sample detects:
Choose in Dec, 2003~2005 year Dec, I am institute's Neonatal Ward and the clinical neonate (age 1d~28d that is in hospital that doubts to bacterial infection (predisposing factor and the clinical manifestation [3] of bacterial infection are all arranged) of NICU, man's 420 examples, woman's 410 examples, premature's 65 examples wherein, all the other are the term infant) 830 examples, it is main that the predisposing factor of these 830 routine neonate's infants and clinical manifestation mainly contain premature, jaundice, pneumonia, enteritis, heating, infectious shock etc.Select neonate's 30 routine samples of being in hospital because of noninfectious disease the same period in contrast.Each 1~2ml of every routine venous blood samples inspects blood culture and the genetic test of bacterial 16 S rRNA quantitative fluorescent PCR respectively by ready samples.
Two, sample detection result
The standard items testing result is seen Fig. 3.The typical curve that detects is seen Fig. 4.
830 routine patient's blood specimen quantitative fluorescent PCRs and blood culture testing result are as follows:
Table 316SrRNA gene by fluorescence quantitative PCR (FQ-PCR) and blood culture Bacteria Detection result contrast
Bacterial 16 S rRNA gene by fluorescence quantitative PCR detects positive rate 5.18% (43/830), blood culture with positive bacteria rate 2.41% (20/830), the former is apparently higher than the latter, and difference has statistical significance P<0.01, and 20 routine sample fluorescence quantitative PCR detection all positive (table 3) of blood culture with positive bacteria.30 routine noninfectious disease infant fluorescence quantitative PCR detection and microbe growth are all negative.If with blood culture in contrast, the diagnostic sensitivity of bacterial fluorescence quantifying PCR method is 100%, and specificity is 97.16%, and correctly diagnosing index is 0.972.
The present invention is described in conjunction with most preferred embodiment, yet after having read foregoing of the present invention, those skilled in the art can make various changes or modifications the present invention, and these equivalent form of values fall within the application's appended claims institute restricted portion equally.
The sequence that the present invention relates to:
<110〉Zhejiang University
<120〉bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit and application thereof
<160>4
<210>1
<211>19
<212>DNA
<213〉artificial sequence
<220>
<223〉bacterial detection 16S rRNA upstream region of gene universal primer sequence
<400>1
CAACGCGAAGAACCTTACC 19
<210>2
<211>18
<212>DNA
<213〉artificial sequence
<220>
<223〉bacterial detection 16S rRNA gene downstream universal primer sequence
<400>2
<210>3
<211>21
<212>DNA
<213〉artificial sequence
<220>
<223〉the general fluorescence probe sequence of bacterial detection 16S rRNA gene
<400>3
TAAGTCCCGCAACGAGCGCAA 21
<210>4
<211>228
<212>DNA
<213〉artificial sequence
<220>
<223〉the fluorescent quantitation examination criteria product sequence that designs according to bacterial 16 S rRNA gene order
<400>4
CAACGCGAAG?AACCTTACCT?GGTCTTGACA?TCCACAGAAC?TTTCCAGAGA?TGGATTGGTG 60
CCTTCGGGAA?CTGTGAGACA?GGTGCTGCAT?GGCTGTCGTC?AGCTCGTGTT?GTGAAATGTT 120
GGGTTAAGTC?CCGCAACGAG?CGCAACCCTT?ATCCTTTGTT?GCCAGCGGTC?CGGCCGGGAA 180
CTCAAAGGAG?ACTGCCAGTG?ATAAACTGGA?GGAAGGTGGG?GATGACGT 228
Claims (1)
1. bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit, it is characterized in that by PCR reactant liquor (1), standard items (2), positive reference substance (3), negative control product (4), extracting lysate (5), operational manual (6), Packaging box body (7) is formed, Packaging box body (7) is provided with container hole, place PCR reactant liquor pipe (1) respectively, standard items (2), positive reference substance (3), negative control product (4), extracting lysate (5), wherein positive reference substance (3) is an Escherichia coli deactivation DNA sample, negative control product (4) are the sterile water for injection sample, PCR reactant liquor (1) is by single tube packing and arranged, and wherein the quantitative PCR reactant liquor contains the PCR damping fluid, MgCl
2, dNTPs, Bacteria Detection with upstream primer, detect with downstream primer, fluorescence probe, hot resistant DNA polymerase, wherein:
The upstream primer sequence is: 5`-CAACGCGAAGAACCTTACC-3`,
The downstream primer sequence is: 5 '-ACGTCATCCCCACCTTCC-3 ',
The fluorescence probe sequence is: 5 '-FAM-TAAGTCCCGCAACGAGCGCAA-TAMRA-3 ',
The standard items sequence is:
CAACGCGAAG?AACCTTACCT?GGTCTTGACA?TCCACAGAAC?TTTCCAGAGA
TGGATTGGTG?CCTTCGGGAA?CTGTGAGACA?GGTGCTGCAT?GGCTGTCGTC
AGCTCGTGTT?GTGAAATGTT?GGGTTAAGTC?CCGCAACGAG?CGCAACCCTT
ATCCTTTGTT?GCCAGCGGTC?CGGCCGGGAA?CTCAAAGGAG?ACTGCCAGTG
ATAAACTGGA?GGAAGGTGGG?GATGACGT
The extracting lysate contains the 10mmol/L Tri-HCl of pH 7.6,5mmol/L disodium ethylene diamine tetraacetate, 0.5% lauryl sodium sulfate; The quantitative PCR reactant liquor must be with 0.22 μ m membrane filtration pre-service.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710070629A CN101144775B (en) | 2007-08-31 | 2007-08-31 | Bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710070629A CN101144775B (en) | 2007-08-31 | 2007-08-31 | Bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101144775A CN101144775A (en) | 2008-03-19 |
CN101144775B true CN101144775B (en) | 2010-05-26 |
Family
ID=39207409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710070629A Expired - Fee Related CN101144775B (en) | 2007-08-31 | 2007-08-31 | Bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101144775B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103789426A (en) * | 2014-01-21 | 2014-05-14 | 浙江大学 | Real-time fluorescent quantitative PCR (Polymerase Chain Reaction) detection kit for Gram positive bacteria |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101649318B (en) * | 2009-07-28 | 2011-07-06 | 鲁辛辛 | Pretreatment method for pathogenic bacteria gene identification in clinical samples |
CN102321740A (en) * | 2011-08-03 | 2012-01-18 | 河北省健海生物芯片技术有限责任公司 | Identification technology and assay kit for infectious bacteria |
CN103789425A (en) * | 2014-01-21 | 2014-05-14 | 浙江大学 | Gram-negative bacteria real-time quantitative PCR (polymerase chain reaction) detection kit |
CN105936945B (en) * | 2016-06-20 | 2019-08-06 | 杭州市第一人民医院 | A kind of multiple reverse transcription quantitative PCR kit of four kinds of Respirovirus of joint inspection |
CN106755301A (en) * | 2016-11-18 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | A kind of real-time fluorescence quantitative PCR kit |
CN109439737A (en) * | 2019-01-09 | 2019-03-08 | 赵志军 | A kind of kit and its diagnostic device for cerebrospinal fluid difficulty pathogen diagnosis |
CN110684853A (en) * | 2019-06-13 | 2020-01-14 | 上海市东方医院(同济大学附属东方医院) | Primer and kit for rapidly detecting bacteria and application of primer and kit |
CN111141678B (en) * | 2020-02-13 | 2024-07-05 | 南京法迈特科技发展有限公司 | Device and method for detecting qualified bacterial liquid rapidly |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1405328A (en) * | 2002-11-08 | 2003-03-26 | 武汉大学 | Fluorescent quantitative PCR kit for rapid and quantitative detecting hog choleravirus and hog cholera lapinized vaccine and its use |
JP2003325181A (en) * | 2002-05-10 | 2003-11-18 | Fuso Pharmaceutical Industries Ltd | Probe for detecting pseudomonas aeruginosa and method using the same |
US20050244836A1 (en) * | 2004-04-28 | 2005-11-03 | Tat-Kin Tsang | Methods and compositions to detect bacteria using multiplex PCR |
CN1710101A (en) * | 2005-06-23 | 2005-12-21 | 武汉大学 | Fluorescent quantitative DCR kit for detecting swine pseudo rabies virus and its use |
CN1814799A (en) * | 2005-12-09 | 2006-08-09 | 浙江大学 | Herpes-like virus gene chip and its use |
WO2006090987A1 (en) * | 2005-02-28 | 2006-08-31 | Bioquest, Inc. | Methods for performing direct enzymatic reactions involving nucleic acid molecules |
EP1818416A2 (en) * | 2004-05-21 | 2007-08-15 | BCS BIOTECH S.p.A. | System for searching for and identifying pathogenic agents |
-
2007
- 2007-08-31 CN CN200710070629A patent/CN101144775B/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003325181A (en) * | 2002-05-10 | 2003-11-18 | Fuso Pharmaceutical Industries Ltd | Probe for detecting pseudomonas aeruginosa and method using the same |
CN1405328A (en) * | 2002-11-08 | 2003-03-26 | 武汉大学 | Fluorescent quantitative PCR kit for rapid and quantitative detecting hog choleravirus and hog cholera lapinized vaccine and its use |
US20050244836A1 (en) * | 2004-04-28 | 2005-11-03 | Tat-Kin Tsang | Methods and compositions to detect bacteria using multiplex PCR |
EP1818416A2 (en) * | 2004-05-21 | 2007-08-15 | BCS BIOTECH S.p.A. | System for searching for and identifying pathogenic agents |
WO2006090987A1 (en) * | 2005-02-28 | 2006-08-31 | Bioquest, Inc. | Methods for performing direct enzymatic reactions involving nucleic acid molecules |
CN1710101A (en) * | 2005-06-23 | 2005-12-21 | 武汉大学 | Fluorescent quantitative DCR kit for detecting swine pseudo rabies virus and its use |
CN1814799A (en) * | 2005-12-09 | 2006-08-09 | 浙江大学 | Herpes-like virus gene chip and its use |
Non-Patent Citations (5)
Title |
---|
JP特开2003325181A 2003.11.18 |
杨祖钦,尚世强 等.脑脊液细菌16S rRNA荧光定量PCR快速诊断儿童化脓性脑膜炎.中国实用儿科杂志22 3.2007,22(3),192-195. |
杨祖钦,尚世强 等.脑脊液细菌16S rRNA荧光定量PCR快速诊断儿童化脓性脑膜炎.中国实用儿科杂志22 3.2007,22(3),192-195. * |
王荣山, 吴亦栋 等.实时荧光定量PCR检测细菌方法的建立及其临床应用.中国围产医学杂志8 4.2005,8(4),242-245. |
王荣山, 吴亦栋 等.实时荧光定量PCR检测细菌方法的建立及其临床应用.中国围产医学杂志8 4.2005,8(4),242-245. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103789426A (en) * | 2014-01-21 | 2014-05-14 | 浙江大学 | Real-time fluorescent quantitative PCR (Polymerase Chain Reaction) detection kit for Gram positive bacteria |
Also Published As
Publication number | Publication date |
---|---|
CN101144775A (en) | 2008-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101144775B (en) | Bacteria real-time fluorescence quantitative polymerase chain reaction detection reagent kit | |
CN102146466B (en) | Reagent for detecting brucella and complex probe fluorescence quantitative PCR (polymerase chain reaction) brucella detection method | |
Tomaso et al. | Comparison of commercial DNA preparation kits for the detection of Brucellae in tissue using quantitative real-time PCR | |
CN101200765B (en) | Gram bacteria retest real-time fluorescent quantitative PCR detection reagent kit and use | |
CN102533959A (en) | Multiplex polymerase chain reaction (PCR) kit for identifying mycobacterium tuberculosis | |
CN101429539B (en) | Reagent kit for real time fluorescence quantitative PCR detection of bacillus pyocyaneus | |
CN112359125A (en) | Method for rapidly detecting cryptococcus gatherensis | |
CN102676664B (en) | Fluorescent quantitative polymerase chain reaction (PCR) primers and probes for detecting pathogenic bacteria of multiple aquatic products simultaneously and detection method | |
CN106434994A (en) | Rapid detecting mycoplasma ovipneumoniae method | |
Nandagopal et al. | Evaluation of a nested PCR targeting IS6110 of Mycobacterium tuberculosis for detection of the organism in the leukocyte fraction of blood samples | |
CN102978282B (en) | Typhoid fever salmonella and salmonella paratyphi fluorescent quantitative polymerase chain reaction (PCR) detection kit and application thereof | |
CN102154487A (en) | Reagent for detecting francisella tularensis and complex probe and fluorescent quantitative polymerase chain reaction (PCR) method for detecting francisella tularensis | |
Elmas et al. | Evaluation of a broad range real-time polymerase chain reaction (RT-PCR) assay for the diagnosis of septic synovitis in horses | |
CN106916903A (en) | The real-time fluorescence RT PCR detection methods and kit of mycobacterium tuberculosis 85B mRNA | |
CN106435007A (en) | Primer, probe, kit and method for detecting bacillus erysipelatos-suis by fluorescent quantitative PCR (Polymerase Chain Reaction) | |
CN104313174A (en) | Molecular beacon probe for rapidly detecting streptococcus pneumoniae and detection method | |
CN201107259Y (en) | Bacteria real time fluorescent fixed quantity polyase chain reaction testing reagent box | |
CN1952174A (en) | LUX fluorescent primer special for detecting bovine herpes virus type I and process for nucleic acid amplification | |
CN201156030Y (en) | Gram bacteria retest real-time fluorescent quantitative PCR detection reagent kit | |
CN110129459B (en) | LAMP primer combination for detecting 5 gram-positive bacteria in intraocular fluid and application | |
CN111534611A (en) | Fluorescent quantitative PCR method for detecting toxigenic streptococcus suis and corresponding kit | |
CN114196767B (en) | Specific molecular target and method for detecting staphylococcus aureus ST type by using same | |
CN110184371B (en) | Specific primer for detecting acinetobacter cutaneus as well as method and application thereof | |
CN103789426A (en) | Real-time fluorescent quantitative PCR (Polymerase Chain Reaction) detection kit for Gram positive bacteria | |
CN114196768B (en) | Specific molecular target for identifying pseudomonas aeruginosa serogroup and rapid detection method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100526 Termination date: 20100831 |